Effect of Acoramidis on Cardiac Conduction Abnormalities in Transthyretin Amyloid Cardiomyopathy

Copies of this presentation and associated educational materials obtained through Quick Response (QR) Code are for personal use only and may not be reproduced without permission from HFSA, the authors of this poster, and the sponsor of the study (BridgeBio Pharma, Inc.)